Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LENALIDOMIDE Cause Diffuse large b-cell lymphoma? 779 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 779 reports of Diffuse large b-cell lymphoma have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.2% of all adverse event reports for LENALIDOMIDE.

779
Reports of Diffuse large b-cell lymphoma with LENALIDOMIDE
0.2%
of all LENALIDOMIDE reports
442
Deaths
112
Hospitalizations

How Dangerous Is Diffuse large b-cell lymphoma From LENALIDOMIDE?

Of the 779 reports, 442 (56.7%) resulted in death, 112 (14.4%) required hospitalization, and 26 (3.3%) were considered life-threatening.

Is Diffuse large b-cell lymphoma Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 779 reports have been filed with the FAERS database.

What Other Side Effects Does LENALIDOMIDE Cause?

Diarrhoea (27,576) Fatigue (22,956) Death (19,213) Off label use (17,017) Rash (15,794) Pneumonia (14,807) Plasma cell myeloma (14,191) Neuropathy peripheral (10,215) White blood cell count decreased (9,996) Constipation (9,635)

What Other Drugs Cause Diffuse large b-cell lymphoma?

RITUXIMAB (1,571) CYCLOPHOSPHAMIDE (1,183) PREDNISONE (1,062) METHOTREXATE (1,055) VINCRISTINE (1,043) DOXORUBICIN (1,002) TACROLIMUS (595) DEXAMETHASONE (539) PREDNISOLONE (506) MYCOPHENOLATE MOFETIL (502)

Which LENALIDOMIDE Alternatives Have Lower Diffuse large b-cell lymphoma Risk?

LENALIDOMIDE vs LENIOLISIB LENALIDOMIDE vs LENOGRASTIM LENALIDOMIDE vs LENVATINIB LENALIDOMIDE vs LEPONEX LENALIDOMIDE vs LERCANIDIPINE

Related Pages

LENALIDOMIDE Full Profile All Diffuse large b-cell lymphoma Reports All Drugs Causing Diffuse large b-cell lymphoma LENALIDOMIDE Demographics